SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-384919
Filing Date
2013-09-30
Accepted
2013-09-30 16:43:32
Documents
4
Period of Report
2013-09-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d606335d8k.htm 8-K 19152
2 EX-99.1 d606335dex991.htm EX-99.1 25419
3 GRAPHIC g606335g47u93.jpg GRAPHIC 3102
4 GRAPHIC g606335g80l76.jpg GRAPHIC 5059
  Complete submission text file 0001193125-13-384919.txt   57286
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 131123748
SIC: 2834 Pharmaceutical Preparations